The number of people with susceptibility test result for rifampicin in Saudi Arabia
Saudi Arabia: The number of people with susceptibility test result for rifampicin was 33.85 in 2021. ▼ Falling
Latest (2021)
33.85
Change on year
down 8.0%
World rank
129th
of 146 countries
All-time high
77.58
in 2018
All-time low
33.85
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Saudi Arabia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Saudi Arabia recorded 33.85 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
The figure is down 8.0% on the previous year and down 43.7% over five years.
That places Saudi Arabia 129th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Saudi Arabia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 60.11 | — |
| 2018 | 77.58 | +29.1% |
| 2019 | 42.07 | -45.8% |
| 2020 | 36.81 | -12.5% |
| 2021 | 33.85 | -8.0% |
Saudi Arabia compared with similar countries
- Saudi Arabia's 33.85 is below the median for high income countries, which is 92.6, 37% of the median. (56 countries reporting)
- Saudi Arabia's 33.85 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 38% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 59.92 | 42.07 | 77.58 | 3 |
| 2020s | 35.33 | 33.85 | 36.81 | 2 |
Countries ranked near Saudi Arabia
More health data for Saudi Arabia
- Un projection of annual infant deaths, annual growth rate -0.8373 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3736 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 483.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 829 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate 5.31 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0384 units per person (2025)
- Population ages 00-04, male, annual growth rate 5.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Saudi Arabia?
- The number of people with susceptibility test result for rifampicin in Saudi Arabia was 33.85 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Saudi Arabia?
- The highest recorded value was 77.58 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Saudi Arabia?
- The lowest recorded value was 33.85 in 2021.
- How does Saudi Arabia rank for the number of people with susceptibility test result for rifampicin?
- Saudi Arabia ranks 129th out of 146 countries with data for 2021.
- Where does this Saudi Arabia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).